You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


Advertisement

ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | RSS | Access Rights | Sign In


  Vol. 148 No. 1, January 2012 TABLE OF CONTENTS
  Online Only
 •  Online First Table of
Contents
  Evidence-Based Dermatology: Study
 •Online Features
 This Article
 •Full text
 •PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Topic Collections
 •Oncology
 •Oncology, Other
 •Dermatology
 •Dermatologic Disorders
 •Quality of Care
 •Evidence-Based Medicine
 •Dermatologic Disorders, Other
 •Hematology/ Hematologic Malignancies
 •Leukemias/ Lymphomas
 •Immunology
 •Immunologic Disorders
 •Alert me on articles by topic
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Delicious Add to Digg Add to Facebook Add to Reddit Add to Technorati Add to Twitter What's this?

Cancer Risk in Patients With Chronic Urticaria

A Population-Based Cohort Study

Yi-Ju Chen, MD, PhD; Chun-Ying Wu, MD, PhD; Jui-Lung Shen, MD; Tzu-Ting Chen, MS; Yun-Ting Chang, MD, PhD

Arch Dermatol. 2012;148(1):103-108. doi:10.1001/archdermatol.2011.682

Objective  To investigate the relative risk of cancer among patients with chronic urticaria in the Taiwanese population.

Design  Retrospective population-based cohort study.

Setting  The National Health Insurance Research Database of Taiwan from January 1, 1996, through December 31, 2008.

Participants  A total of 12 720 patients with chronic urticaria, with long-term antihistamine use and no history of malignant tumors, autoimmune diseases, atopy, or allergic diseases.

Main Outcome Measure  Relative cancer risk calculated by standardized incidence ratios.

Results  There were 704 cancers among chronic urticaria patients. An increased risk of cancer (standardized incidence ratio, 2.2; 95% CI, 2.0-2.3), especially hematologic malignant tumor (4.1; 3.1-5.4), was observed. The relative risk of cancer varied by age and was highest among those aged 20 to 39 years in comparison with the general population. Most cancer cases were detected within the first year of diagnosis. The risk of non-Hodgkin lymphoma was greatest (standardized incidence ratio, 4.4; 95% CI, 3.0-6.1) among the hematologic cancers.

Conclusions  Patients with chronic urticaria are at increased risk of cancer, especially hematologic malignant tumors. Further studies are needed to delineate the associations.


Author Affiliations: Department of Dermatology (Dr Chen) and Faculty of Medicine (Dr Wu), National Yang-Ming University, Taipei; Division of Gastroenterology (Drs Wu and Chang and Ms Chen) and Department of Dermatology (Drs Chen and Shen), Taichung Veterans General Hospital, and Department of Life Sciences, National Chung-Hsing University (Dr Wu), Taichung; Department of Public Health, College of Public Health, China Medical University, Taichung (Dr Shen); and Department of Dermatology, Taipei Veterans General Hospital and National Yang-Ming University, Taipei (Dr Chang), Taiwan.



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Delicious Delicious   Add to Digg Digg   Add to Facebook Facebook   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | PHYSICIAN JOBS | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2012 American Medical Association. All Rights Reserved.